Phenotypes and Endotypes in Interstitial Lung Diseases—Second Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 1244
Special Issue Editor
Interests: interstitial lung disease; pulmonary fibrosis; orphan lung diseases; non-cystic fibrosis bronchiectasis; pneumonia/pulmonary infection; sarcoidosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Interstitial lung diseases (ILDs) are a heterogeneous group of more than 200 entities of either known or unknown etiology. The heterogeneity seen in ILDs manifests at many levels, including their symptoms, disease course, radiological and histological features, and biological underpinnings. This heterogeneity has been a substantial barrier to understanding the mechanisms of these diseases and developing effective and personalized treatments. Despite the growing interest and clinical research into ILDs, the management of patients remains sub-optimal, mainly because of the limited knowledge of the diseases’ pathogenesis, the highly variable and unpredictable behavior of the diseases, and their heterogeneous responses to treatment. Recent data suggest that different ILDs may share similar pathogenetic and biological pathways and thus be amenable to the same treatment. A paradigmatic example is the progressive pulmonary fibrosis (PPF) phenotype, in which nintedanib, a tyrosine kinase inhibitor targeting the PDGF and several other growth factors, has shown efficacy regardless of ILD etiology. A growing amount of evidence points towards the subgroup characterization of ILDs through endotypes, which are defined by specific genetic and molecular biomarkers. Thus, the future of ILDs lies in precision medicine approaches that are based on phenotypic and endotypic features. The aim of this Special Issue is to outline the status of knowledge in this field.
Dr. Francesco Amati
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interstitial lung diseases (ILDs)
- heterogeneity
- pathogenesis
- progressive pulmonary fibrosis (PPF)
- molecular biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Phenotypes and Endotypes in Interstitial Lung Diseases in Biomedicines (8 articles)
